雲圖控股(002539.SZ):獲批鄭州商品交易所指定尿素交割廠庫
格隆匯6月4日丨雲圖控股(002539.SZ)公佈,公司於2020年5月18日召開的第五屆董事會第十一次會議,審議通過了《關於全資子公司申請純鹼和尿素指定交割倉庫資質的議案》,公司同意全資子公司應城市新都化工有限責任公司、嘉施利(平原)化肥有限公司(“平原嘉施利公司”)向鄭州商品交易所(“鄭商所”)分別申請純鹼、尿素指定交割倉庫資質。
鄭商所於2021年6月4日發佈了《關於增設指定尿素交割廠庫的公吿》(〔2021〕42號),明確公司成為鄭商所尿素指定交割廠庫,本次提貨點設在公司的全資子公司平原嘉施利公司,自2021年6月14日起實施。
此次指定將進一步提高公司的資產使用效率,提升公司的規範管理水平,同時有利於擴大公司在業內的影響力和知名度。公司將充分利用尿素交割廠庫的特性,把現貨市場、期貨市場、交割倉庫三者有機結合,推進尿素供應鏈快速發展,增強公司的核心競爭力,進一步提高公司的盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.